Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Lymphatic Research and Biology|December 16, 2014
The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational studyAtilla Soran, Tolga Ozmen, Kandace P McGuire, et al.
American Journal of Clinical Oncology|December 3, 2011
Rationale of excisional biopsy after the diagnosis of benign radial scar on core biopsy: a single institutional outcome analysisOya Andacoglu, Amal Kanbour-Shakir, Yew-Ching Teh, et al.
Breast Cancer Research and Treatment|February 22, 2023
Single-institution outcomes after excision of benign phyllodes tumors: low recurrence risk even with positive marginsZainab Balogun, Jennifer G Steiman, Jandie L Schwartz, et al.
Annals of Surgical Oncology|December 9, 2024
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is AdministeredNeslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
Annals of Surgical Oncology|September 28, 2011
MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?Kandace P McGuire, Jorge Toro-Burguete, Hang Dang, et al.
American Journal of Clinical Oncology|May 8, 2013
Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancerAtilla Soran, Ahmad Ibrahim, Malak Kanbour, et al.
World Journal of Surgical Oncology|April 10, 2009
Breast cancer risk factors in Turkish women--a University Hospital based nested case control studyVahit Ozmen, Beyza Ozcinar, Hasan Karanlik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28Eleftherios P Mamounas, John Bryant, Barry Lembersky, et al.
Annals of Surgical Oncology|June 18, 2021
Association of Tumor Molecular Subtype and Stage with Breast and Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast CancerSara P Myers, Gillian M Ahrendt, Joanna S Lee, et al.
Cancer|February 5, 2010
Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 casesRohit Bhargava, Sushil Beriwal, David J Dabbs, et al.
Pageof 12